iRhythm Holdings Inc IRTC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
IRTC Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into iRhythm Technologies, Inc. (IRTC)
iRhythm Holdings to Participate in Upcoming Investor Conferences
iRhythm Holdings Announces Third Quarter 2026 Financial Results
iRhythm Holdings to Report Third Quarter 2026 Financial Results on November 5, 2026
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
iRhythm Completes Acquisition of VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care
iRhythm Provides Update on Cybersecurity Incident Previously Disclosed in June 2026
Here's how to position your portfolio for the next AI wave, according to Morgan Stanley
Trading Information
- Previous Close Price
- $130.19
- Day Range
- $86.30–112.95
- 52-Week Range
- $86.30–192.47
- Bid/Ask
- $90.00 / $90.76
- Shares Outstanding
- 33.19M
- Market Cap
- $2.97B
- Volume/Avg
- 6M / 578,509
Key Statistics
- Price/Earnings (Normalized)
- 189.69
- Price/Sales
- 3.45
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 2,400
- Website
- https://www.irhythmtech.com
Valuation
Metric | IRTC |
|---|---|
Price/Earnings (Normalized) | 189.69 |
Price/Book Value | 16.90 |
Price/Sales | 3.45 |
Price/Cash Flow | 16.99 |
Price/Earnings
IRTC
Financial Strength
Metric | IRTC |
|---|---|
Quick Ratio | 3.32 |
Current Ratio | 3.57 |
Interest Coverage | −3.34 |
Quick Ratio
IRTC
Profitability
Metric | IRTC |
|---|---|
Return on Assets (Normalized) | 7.00% |
Return on Equity (Normalized) | 45.60% |
Return on Invested Capital (Normalized) | 7.50% |
Return on Assets
IRTC
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|DsN%kL | LOCK|Sh@< | $190B | |||
| Medtronic PLC MDT | LOCK|@!!Pv!W | LOCK|l^?p | $130B | |||
| Stryker Corp SYK | LOCK|%RM#c^@^ | LOCK|!n | $124B | |||
| Boston Scientific Corp BSX | LOCK|?$Lh&Y& | LOCK|^f<x | $62B | |||
| Edwards Lifesciences Corp EW | LOCK|!QTh&<d | LOCK|GTk@! | $59B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|&<BlF>L | LOCK|W!% | $37B | |||
| Koninklijke Philips NV ADR PHG | LOCK|?# | LOCK|%# | $30B | |||
| DexCom Inc DXCM | LOCK|c^^jtFWk | LOCK|b<GDv | $30B | |||
| Steris PLC STE | LOCK|LBb$!K | LOCK|B#PS | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|v$>?G!@ | LOCK|%@ | $20B |
United States